Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-02

Clinical Trial Update: Impact of Ketoflex 12/3 Diet on Parkinson's Disease Symptoms: A Clinical Study [NA]

View source ↗

Summary

A completed clinical trial evaluated the impact of the Ketoflex 12/3 diet on symptoms of Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Istanbul Medipol University Hospital | Conditions: Parkinson's Disease, Parkinson | NA | Status: COMPLETED